Ablavar information

ABLAVAR®: unique chemistry at work

ABLAVAR® is a unique contrast agent specifically designed to overcome the limitations of MRA imaging with extracellular contrast agents.3

The ABLAVAR® difference is its reversible binding to the blood protein albumin.This binding allows ABLAVAR® to remain in the circulation (the “blood pool”) for up to 1 hour.1,3 As a result, high-resolution, finely detailed MRA images can be obtained in order to visualize the extent and severity of vascular pathology — all with a single, low-dose injection.1,3,4

ABLAVAR® (gadofosveset trisodium) is the first and only FDA-approved gadolinium-based contrast agent designed specifically for magnetic resonance angiography (MRA). ABLAVAR®-enhanced MRA is an innovative approach to evaluating aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease1,2

A single dose of ABLAVAR® contains the lowest dose of gadolinium of all contrast agents used in MRA*


This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s